This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Cardiovascular System  • Cardiovascular Disease/ Myocardial Infarction  • Alert me on articles by topic  Social Bookmarking   What's this?

Swift Treatment Needed to Boost MI Survival

Mike Mitka

JAMA. 2007;298(24):2853-2854.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Orlando, Fla—Health care workers understand the importance of quick delivery of reperfusion therapy for patients with ST-segment elevation myocardial infarction (STEMI). Studies have shown that hospitals and their staffs can often shorten the time between a patient's arrival and initiation of primary percutaneous coronary intervention (PCI) or delivery of fibrinolytic therapy to clear an arterial blockage. Yet many institutions have not shaved off those potentially lifesaving minutes.

Researchers hope to find ways to hasten the delivery of therapies that restore circulation in blocked coronary arteries to patients who are experiencing myocardial infarction. (Photo credit: Doug Martin/www.sciencesource.com)

At the Scientific Sessions of the American Heart Association, held here in November, several presentations suggested ways to improve reperfusion therapy delivery time and noted areas needing improvement. STEMI strikes about 500 000 people in the United States every year, said Alice Jacobs, MD, past president of the American Heart . . . [Full Text of this Article]

OUTSIDE THE HOSPITAL



CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?